"Designing Growth Strategies is in our DNA"

Heparin Market Size, Share & COVID-19 Impact Analysis, By Product (Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH)), By Source (Bovine and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion and Subcutaneous Injection), By End-user (Hospitals & ASCs, Clinics, and Others), and Regional Forecast, 2023-2030

Region : Global | Format: PDF | Report ID: FBI104447

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Key Industry Developments -Mergers, Acquisitions, and Partnerships
    2. New Product Launches
    3. Prevalence of Key Cardiovascular Diseases, By Key Countries
    4. Blood Clots: Stats & Facts
    5. Overview of Technological Advancements in Heparin
    6. Impact of COVID-19 on the Global Heparin Market
    7. Regulatory Scenario by Key Countries/ Region
    8. Reimbursement Scenario by Key Countries/ Region
    9. China Heparin Market Overview (Production/ Supply Impacted by Swine Fever, etc.)
    10. Pricing of Heparin
  5. Global Heparin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Heparin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Heparin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Heparin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Heparin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Heparin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Opocrin S.p.A.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      2. Baxter
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      3. Pfizer Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      4. Bioiberica S.A.U.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      5. Fresenius SE & Co. KgaA
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      6. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      7. B. Braun SE
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      8. Dr. Reddy’s Laboratories Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      9. LEO Pharma A/S
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      10. Aspen Holdings
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
      11. Sanofi
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies, Financials (Based on Availability)
Read Less

Figure 1:  Global Heparin Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030

Figure 2:  Global Heparin Market Value Share (%), by Product, 2022 & 2030

Figure 3:  Global Heparin Market Value Share (%), by Source, 2022 & 2030

Figure 4:  Global Heparin Market Value Share (%), by Application, 2022 & 2030

Figure 5:  Global Heparin Market Value Share (%), by Route of Administration, 2022 & 2031

Figure 6:  Global Heparin Market Value Share (%), by End-user, 2022 & 2030

Figure 7:  Global Heparin Market Value (USD billion), by Region, 2022 & 2030

Figure 8:  North America Heparin Market Value (USD billion), by Product, 2022 & 2030

Figure 9:  North America Heparin Market Value Share (%), by Product, 2022

Figure 10:  North America Heparin Market Value (USD billion), by Source, 2022 & 2030

Figure 11:  North America Heparin Market Value Share (%), by Source, 2022

Figure 12:  North America Heparin Market Value (USD billion), by Application, 2022 & 2030

Figure 13:  North America Heparin Market Value Share (%), by Application, 2022

Figure 14:  North America Heparin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 15:  North America Heparin Market Value Share (%), by Route of Administration, 2022

Figure 16:  North America Heparin Market Value (USD billion), by End-user, 2022 & 2030

Figure 17:  North America Heparin Market Value Share (%), by End-user, 2022

Figure 18:  North America Heparin Market Value (USD billion), By Country, 2022 & 2030

Figure 19:  North America Heparin Market Value Share (%), By Country, 2022

Figure 20:  Europe Heparin Market Value (USD billion), by Product, 2022 & 2030

Figure 21:  Europe Heparin Market Value Share (%), by Product, 2022

Figure 22:  Europe Heparin Market Value (USD billion), by Source, 2022 & 2030

Figure 23:  Europe Heparin Market Value Share (%), by Source, 2022

Figure 24:  Europe Heparin Market Value (USD billion), by Application, 2022 & 2030

Figure 25:  Europe Heparin Market Value Share (%), by Application, 2022

Figure 26:  Europe Heparin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 27:  Europe Heparin Market Value Share (%), by Route of Adminitration, 2022

Figure 28:  Europe Heparin Market Value (USD billion), by End-user, 2022 & 2030

Figure 29:  Europe Heparin Market Value Share (%), by End-user, 2022

Figure 30:  Europe Heparin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 31:  Europe Heparin Market Value Share (%), By Country/ Sub-region, 2022

Figure 32:  Asia Pacific Heparin Market Value (USD billion), by Product, 2022 & 2030

Figure 33:  Asia Pacific Heparin Market Value Share (%), by Product, 2022

Figure 34:  Asia Pacific Heparin Market Value (USD billion), by Source, 2022 & 2030

Figure 35:  Asia Pacific Heparin Market Value Share (%), by Source, 2022

Figure 36:  Asia Pacific Heparin Market Value (USD billion), by Application, 2022 & 2030

Figure 37:  Asia Pacific Heparin Market Value Share (%), by Application, 2022

Figure 38:  Asia Pacific Heparin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 39:  Asia Pacific Heparin Market Value Share (%), by Route of Administration, 2022

Figure 40:  Asia Pacific Heparin Market Value (USD billion), by End-user, 2022 & 2030

Figure 41:  Asia Pacific Heparin Market Value Share (%), by End-user, 2022

Figure 42:  Asia Pacific Heparin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 43:  Asia Pacific Heparin Market Value Share (%), By Country/ Sub-region, 2022

Figure 44:  Latin America Heparin Market Value (USD billion), by Product, 2022 & 2030

Figure 45:  Latin America Heparin Market Value Share (%), by Product, 2022

Figure 46:  Latin America Heparin Market Value (USD billion), by Source, 2022 & 2030

Figure 47:  Latin America Heparin Market Value Share (%), by Source, 2022

Figure 48:  Latin America Heparin Market Value (USD billion), by Application, 2022 & 2030

Figure 49:  Latin America Heparin Market Value Share (%), by Application, 2022

Figure 50:  Latin America Heparin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 51:  Latin America Heparin Market Value Share (%), by Route of Administration, 2022

Figure 52:  Latin America Heparin Market Value (USD billion), by End-user, 2022 & 2030

Figure 53:  Latin America Heparin Market Value Share (%), by End-user, 2022

Figure 54:  Latin America Heparin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 55:  Latin America Heparin Market Value Share (%), By Country/ Sub-region, 2022

Figure 56:  Middle East & Africa Heparin Market Value (USD billion), by Product, 2022 & 2030

Figure 57:  Middle East & Africa Heparin Market Value Share (%), by Product, 2022

Figure 58:  Middle East & Africa Heparin Market Value (USD billion), by Source, 2022 & 2030

Figure 59:  Middle East & Africa Heparin Market Value Share (%), by Source, 2022

Figure 60:  Middle East & Africa Heparin Market Value (USD billion), by Application, 2022 & 2030

Figure 61:  Middle East & Africa Heparin Market Value Share (%), by Application, 2022

Figure 62:  Middle East & Africa Heparin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 63:  Middle East & Africa Heparin Market Value Share (%), by Route of Administration, 2022

Figure 64:  Middle East & Africa Heparin Market Value (USD billion), by End-user, 2022 & 2030

Figure 65:  Middle East & Africa Heparin Market Value Share (%), by End-user, 2022

Figure 66:  Middle East & Africa Heparin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 67:  Middle East & Africa Heparin Market Value Share (%), By Country/ Sub-region, 2022

Figure 68:  Global Heparin Market Share (%), By Company, 2022

Table 1:  Global Heparin Market Revenue (USD billion) Forecast, by Product, 2019–2030

Table 2:  Global Heparin Market Revenue (USD billion) Forecast, by Source, 2019–2030

Table 3:  Global Heparin Market Revenue (USD billion) Forecast, by Application, 2019–2030

Table 4:  Global Heparin Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2030

Table 5:  Global Heparin Market Revenue (USD billion) Forecast, by End-user, 2019–2030

Table 6:  Global Heparin Market Revenue (USD billion) Forecast, by Region, 2019-2030

Table 7:  North America Heparin Market Revenue (USD billion) Forecast, by Product, 2019-2030

Table 8:  North America Heparin Market Revenue (USD billion) Forecast, by Source, 2019-2030

Table 9:  North America Heparin Market Revenue (USD billion) Forecast, by Application, 2019-2030

Table 10:  North America Heparin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 11:  North America Heparin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 12:  North America Heparin Market Revenue (USD billion) Forecast, By Country, 2019-2030

Table 13:  Europe Heparin Market Revenue (USD billion) Forecast, by Product, 2019-2030

Table 14:  Europe Heparin Market Revenue (USD billion) Forecast, by Source, 2019-2030

Table 15:  Europe Heparin Market Revenue (USD billion) Forecast, by Application, 2019-2030

Table 16:  Europe Heparin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 17:  Europe Heparin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 18:  Europe Heparin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 19:  Asia Pacific Heparin Market Revenue (USD billion) Forecast, by Product, 2019-2030

Table 20:  Asia Pacific Heparin Market Revenue (USD billion) Forecast, by Source, 2019-2030

Table 21:  Asia Pacific Heparin Market Revenue (USD billion) Forecast, by Application, 2019-2030

Table 22:  Asia Pacific Heparin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 23:  Asia Pacific Heparin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 24:  Asia Pacific Heparin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 25:  Latin America Heparin Market Revenue (USD billion) Forecast, by Product, 2019-2030

Table 26:  Latin America Heparin Market Revenue (USD billion) Forecast, by Source, 2019-2030

Table 27:  Latin America Heparin Market Revenue (USD billion) Forecast, by Application, 2019-2030

Table 28:  Latin America Heparin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 29:  Latin America Heparin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 30:  Latin America Heparin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 31:  Middle East & Africa Heparin Market Revenue (USD billion) Forecast, by Product, 2019-2030

Table 32:  Middle East & Africa Heparin Market Revenue (USD billion) Forecast, by Source, 2019-2030

Table 33:  Middle East & Africa Heparin Market Revenue (USD billion) Forecast, by Application, 2019-2030

Table 34:  Middle East & Africa Heparin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 35:  Middle East & Africa Heparin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 36:  Middle East & Africa Heparin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Booklet
  • May, 2023
  • 2022
  • 2019-2021
  • 200

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X